Romeo, Marzia Anita Lucia
Garassino, Marina Chiara
Moiola, Lucia
Galli, Giulia
Comi, Giancarlo
Martinelli, Vittorio
Filippi, Massimo http://orcid.org/0000-0002-5485-0479
Article History
Received: 8 September 2019
Revised: 25 September 2019
Accepted: 26 September 2019
First Online: 4 October 2019
Compliance with ethical standards
:
: M. Romeo received honoraria from Sanofi Genzyme, Merck-Serono, and support for traveling from Novartis, Almirall and Teva Pharmaceutical Industries; M. Garassino received personal fees from AstraZeneca, Roche, BMS, MSD; L. Moiola received honoraria from Sanofi Genzyme, TEVA Pharmaceutical Industries, Novartis, Merck-Serono and Biogen Idec; G. Galli report no disclosures; G. Comi received compensation for consulting services and speaking activities from Novartis, Teva Pharmaceutical Industries, Sanofi Genzyme, Merck-Serono, Biogen Idec, Roche, Almirall, Celgene, Forward Pharma, Medday and Excemed; V. Martinelli received honoraria from Sanofi Genzyme, Biogen Idec, TEVA Pharmaceutical Industries, Bayer, Merck-Serono and Novartis; M. Filippi is Editor-in-Chief of the Journal of Neurology; received compensation for consulting services and/or speaking activities from Biogen Idec, Merck-Serono, Novartis, Teva Pharmaceutical Industries; and receives research support from Biogen Idec, Merck-Serono, Novartis, Teva Pharmaceutical Industries, Roche, Italian Ministry of Health, Fondazione Italiana Sclerosi Multipla, and ARiSLA (Fondazione Italiana di Ricerca per la SLA).
: A written informed consent was obtained from the patient for the publication of this case.